Consistently, a decrease in CCAT2 was observed in both luminal A and luminal B breast tumor samples, compared to matched adjacent normal mammary tissues (Figure 1B), which was further confirmed in 609 luminal breast cancer tumors from the TCGA database (Figure 1C). The gene discussed is CCAT2; the disease is breast carcinoma.